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The increase of methicillin-resistant Staphylococcus aureus (MRSA) and
vancomycin-resistant Enterococcus (VRE) poses a worldwide and serious health
threat. Although new antibiotics, such as daptomycin and linezolid, have been
developed for the treatment of infections of Gram-positive pathogens, the emergence
of daptomycin-resistant and linezolid-resistant strains during therapy has now increased
clinical treatment failures. In the past few years, studies using quantitative proteomic
methods have provided a considerable progress in understanding antibiotic resistance
mechanisms. In this review, to understand the resistance mechanisms to four clinically
important antibiotics (methicillin, vancomycin, linezolid, and daptomycin) used in the
treatment of Gram-positive pathogens, we summarize recent advances in studies
on resistance mechanisms using quantitative proteomic methods, and also examine
proteins playing an important role in the bacterial mechanisms of resistance to the four
antibiotics. Proteomic researches can identify proteins whose expression levels are
changed in the resistance mechanism to only one antibiotic, such as LiaH in daptomycin
resistance and PrsA in vancomycin resistance, and many proteins simultaneously
involved in resistance mechanisms to various antibiotics. Most of resistance-related
proteins, which are simultaneously associated with resistance mechanisms to several
antibiotics, play important roles in regulating bacterial envelope biogenesis, or
compensating for the fitness cost of antibiotic resistance. Therefore, proteomic data
confirm that antibiotic resistance requires the fitness cost and the bacterial envelope is
an important factor in antibiotic resistance.
Keywords: quantitative proteomics, methicillin resistance, vancomycin resistance, linezolid resistance,
daptomycin resistance
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Introduction
Antibiotic resistance has posed a serious threat to the
worldwide public health in the past two decades. The
gradual increase in resistance rates of several important
pathogens, including methicillin-resistant Staphylococcus aureus
(MRSA), vancomycin-resistant Enterococcus (VRE), multidrug-
resistant (MDR) Pseudomonas aeruginosa, imipenem-resistant
Acinetobacter baumannii, and third-generation cephalosporin-
resistant Escherichia coli and Klebsiella pneumonia, has become
an increasingly severe problem in many hospitals worldwide
(Lee et al., 2013). However, the decline in novel antibiotics that
are introduced in the market weakens the hope of overcoming
this threat by the development of new antibiotics. Most of
the antibiotic classes used in hospitals today were discovered
during the period 1930–1960. Only two new systemic classes
of antibiotics that were developed during the past 30 years
were linezolid and daptomycin, which are used only in the
treatment of Gram-positive pathogens (Lee et al., 2013). Because
many Gram-positive pathogens increasingly develop resistance
against currently available antibiotics such as methicillin and
vancomycin, these new antibiotics have become valuable for the
treatment of various infections of methicillin- or vancomycin-
resistant S. aureus and Streptococcus pneumonia (Ament et al.,
2002; Mendes et al., 2014). However, the emergence of
daptomycin-resistant or linezolid-resistant strains has recently
been described in some Gram-positive pathogens (Fischer et al.,
2011; Mendes et al., 2014). In this review, we summarize
resistance mechanisms to four clinically important antibiotics
(methicillin, vancomycin, linezolid, and daptomycin) used in
the treatment of Gram-positive pathogens, and highlights
recent important studies using comparative proteomic tools to
understand resistance mechanisms of these antibiotics in more
detail.
Action and Resistance Mechanisms of
Methicillin, Vancomycin, Linezolid, and
Daptomycin Resistance
Methicillin
Methicillin is a narrow-spectrum β-lactam antibiotic of the
penicillin class. Like other β-lactam antibiotics, methicillin
prevents the synthesis of bacterial cell walls by inhibiting
peptidic cross-linkage between the linear peptidoglycan polymer
TABLE 1 | Modes of action of four clinically important antibiotics (methicillin, vancomycin, linezolid, and daptomycin) and resistance mechanisms to
these antibiotics.




Inhibition of peptidoglycan biosynthesis Expression of penicillin-binding protein 2a (MecA), efflux pump
Vancomycin D-Ala-D-Ala dipeptide terminus of the
nascent peptidoglycan
Inhibition of peptidoglycan biosynthesis Alteration of the D-Ala-D-Ala dipeptide
Linezolid 23S rRNA Inhibition of translation Alteration of 23S rRNA
Daptomycin Cell membrane The formation of holes that leak intracellular ions Remained to be elucidated
chains, which provides rigidity to the cell wall of Gram-
positive bacteria (Chambers, 1997) (Table 1). Methicillin and
other β-lactam antibiotics are structural analogs of D-Ala-
D-Ala, which is the terminus of a short amino acid chain
attached in N-acetylmuramic acids; so, they interact with
and irreversibly inhibit the transpeptidase enzyme [also called
penicillin-binding protein (PBP)] that crosslinks the linear
peptidoglycan polymer chains (Lee et al., 2012). This process
leads to loss of osmotic integrity and makes the bacterial cells
susceptible to lysis. Although most β-lactam antibiotics are
inhibited by bacterial enzymes that hydrolyze the β-lactam ring
(named β-lactamases), due to a modiﬁcation of the original
penicillin structure methicillin is resistant to β-lactamases (Lee
et al., 2012). Therefore, since the late 1950s when methicillin
was ﬁrst introduced in markets, this antibiotic has been used
to treat infections caused by Staphylococcus pathogens such
as Staphylococcus aureus, most of which produces β-lactamase
(Newsom, 2004).
Today, methicillin is not as eﬀective against these organisms
due to resistance (Cordwell et al., 2002; Newsom, 2004).
Although the resistance phenotype of methicillin is inﬂuenced by
numerous factors, including mecA, glmM, fmtAB, murE, llm, β-
lactamase (bla) regulatory elements, and fem factors (Chambers,
1997; Cordwell et al., 2002; Hao et al., 2012), one major reason
for methicillin resistance is the expression of the mecA gene,
encoding penicillin-binding protein 2a (PBP 2a) that is not
inhibited by classical β-lactam antibiotics including methicillin
(Katayama et al., 2004) (Table 1). PBP 2a works in a similar
manner to other PBPs, but it is bound by β-lactams with very
low aﬃnity (Katayama et al., 2004). Expression of PBP 2a confers
resistance to all β-lactams. A variety of factors such as MecI
and MecR1 controlled the mecA expression (Chambers, 1997).
Resistance to methicillin exhibited by strains lacking the mecA
gene is associated with modiﬁcations in native PBPs, β-lactamase
hyperproduction, or possibly a methicillinase (Chambers, 1997).
In pathogenesis, it has been reported that some virulence factors
(Panton-Valentine leukocidin, phenol-soluble modulin, arginine
catabolic mobile element, and other toxin elements) and two-
component regulation systems (agr, saeRS, and vraRS) involved
in pathogenesis can enhance the ﬁtness of methicillin-resistant
pathogens (Hao et al., 2012).
Vancomycin
Vancomycin made by the soil bacterium Amycolatopsis orientalis
is a member of the glycopeptide antibiotic class and has an
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important role in the treatment of serious infections caused by
Gram-positive bacteria such as Staphylococcus and Streptococcus
(Woodford, 1998). It is a complex compound consisting of a
branched tricyclic glycosylated peptide and is a rare example
of a halo-organic natural compound containing two covalently
bonded chlorine atoms (Levine, 2006). Vancomycin inhibits the
peptidoglycan synthesis by binding at the D-Ala-D-Ala dipeptide
terminus of the nascent peptidoglycan in Gram-positive bacteria
(Healy et al., 2000; Levine, 2006). This binding of vancomycin
to the D-Ala-D-Ala prevents the peptidic cross-linking between
the linear peptidoglycan polymer chains by inhibiting the proper
interaction with the transpeptidase enzyme (Healy et al., 2000)
(Table 1).
Most Gram-negative bacteria are intrinsically resistant to
vancomycin because it cannot penetrate the outer membrane
of Gram-negative bacteria. In Gram-positive bacteria, one
mechanism of resistance to vancomycin is the alteration of
the terminal amino acid residues (D-Ala-D-Ala), to which
vancomycin binds (Table 1). The D-Ala-D-Ala dipeptide
terminus of the nascent peptidoglycan is replaced by D-Ala-
D-Lac or D-Ala-D-Ser. The D-Ala-D-Lac variation results in
a 1000-fold decrease in the aﬃnity between vancomycin and
the peptide, and the D-Ala-D-Ser variation causes a 6-fold
loss of aﬃnity, most likely due to steric hindrance (Courvalin,
2005). These alterations of the D-Ala-D-Ala dipeptide terminus
require the coordinate action of several enzymes encoded
by the van genes. Alternative ligases catalyze the formation
of the D-Ala-D-Lac peptide (VanA, B, and D type enzymes)
or D-Ala-D-Ser peptide (VanC, E, and G type enzymes) in
peptidoglycan synthesis. VanH protein (α-keto acid reductase)
reduces pyruvate to D-Lac, and the D,D-dipeptidase VanX
selectively removes the D-Ala-D-Ala produced by the native
ligase to enhance the incorporation of the D-Ala-D-Lac or
D-Ala-D-Ser into the peptidoglycan precursor. VanR and VanS
constitute a two-component regulatory system that activates the
transcription of the van gene cluster (Marcone et al., 2010).
Linezolid
Linezolid is a ﬁrst synthetic oxazolidinone antibiotic used to treat
infections caused by VRE and MRSA. Although the mechanism
of action of linezolid is not fully understood, it seems to bind
to the 50S subunit of the bacterial ribosome through interaction
with the central loop of the 23S rRNA and block the formation
of protein synthesis initiation complexes (Swaney et al., 1998;
Ament et al., 2002) (Table 1). Because linezolid binds to the
23S portion of the 50S subunit diﬀerent from the binding sites
of other ribosome-binding antibiotics such as chloramphenicol,
cross-resistance between linezolid and other protein synthesis
inhibitors is highly rare (Herrmann et al., 2008). The crystal
structures of linezolid bound to the 50S subunit in 2008 showed
that linezolid binds to the A site of the 50S ribosomal subunit
and induces a conformational change perturbing the correct
positioning of tRNAs on the ribosome (Ippolito et al., 2008;
Wilson et al., 2008).
Most Gram-negative bacteria have an intrinsic resistance to
linezolid due to the high activity of eﬄux pumps, which actively
pump linezolid out of the cell (Schumacher et al., 2007). In
Gram-positive bacteria, the acquired resistance to linezolid was
ﬁrst reported in 1999 inmultidrug-resistant Enterococcus faecium
(Mendes et al., 2014). High-resolution structures of linezolid
with the 50S ribosomal subunit showed that it binds to a deep
cleft that is surrounded by the central loop of domain V of 23S
rRNA (Long and Vester, 2012). Therefore, the most common
resistance mechanism of Gram-positive bacteria to linezolid was
a point mutation known as G2576T, in which the G2576 position
of 23S ribosomal RNA is converted to thymine (Mendes et al.,
2014). In addition to mutations in 23S rRNA, other mechanisms
have been identiﬁed in Gram-positive bacteria, including a six
base pair deletion in the ribosomal protein L4, mutations in the
ribosomal protein L3, mutations in an RNA methyltransferase
(encoded by the cfr gene) that methylates G2445 of the 23S rRNA,
and mutations causing increased expression of ABC transporter
genes (patA and patB).
Daptomycin
Daptomycin is a lipopeptide antibiotic consisting of a lipid
molecule conjugated with anionic peptide and is a natural
compound found in the soil bacterium Streptomyces roseosporus
(Miao et al., 2005). Daptomycin absolutely requires Ca2+ for
activity, making this agent a cationic antimicrobial peptide
functionally (Baltz, 2009). The poorly calcium-decorated form
of daptomycin is 10 times less active microbiologically than
the heavily calcium-decorated form (Baltz, 2009). The calcium-
bound daptomycin interacts with phosphatidylglycerol in the
bacterial membrane and inserts into the cell membrane, leading
to the formation of holes that leak intracellular ions (Pogliano
et al., 2012). A loss of membrane potential causes inhibition of
protein, DNA, and RNA synthesis, which results in bacterial cell
death (Pogliano et al., 2012). Because of a distinct mechanism
of action of daptomycin, it is used in the treatment of
life-threatening infections caused by multiple drug-resistant
Gram-positive bacteria (Baltz, 2009). Because vancomycin and
daptomycin have molecular weight (MWs) of more than 1000
Da (vancomycin of 1449 Da and daptomycin of 1620 Da), they
cannot penetrate the outer membrane of Gram-negative bacteria
(Lee et al., 2013). Therefore, two antibiotics are used to control
infections caused by Gram-positive bacteria.
Although daptomycin was clinically introduced in 2003,
clinical treatment failures by the emergence of daptomycin-
resistant strains during therapy have now been described (Hobbs
et al., 2008; Fischer et al., 2011). Up to now, speciﬁc genetic
determinant of the daptomycin-resistant strain remained to
be elucidated, despite the ﬁnding of several phenotypic and
genetic determinants (altered phospholipid synthesis, thickened
cell walls, alteration of cell membrane ﬂuidity, and the acquisition
of mutations within the mprF or yycG gene) (Mishra et al.,
2009; Fischer et al., 2011). The mprF gene encodes a dual
functional enzyme that catalyzes the coupling of lysine to
phosphatidylglycerol (PG) and transfers the lysyl-PG (LPG) to
the outer leaﬂet of the membrane. The LPG is less acidic than
PG, and membranes lacking LPG are more acidic than those
containing PG and LPG (Baltz, 2009). Daptomycin-resistant
strains with mprF mutations have membranes with increased
levels of LPG (Jones et al., 2008). Therefore, the increased positive
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charge caused by increased LPG in the mprF mutant (gain-of-
function) reduces the binding of Ca2+-bound daptomycin to
bacterial membranes by a less favorable electrostatic interaction.
YycG is a membrane spanning sensor histidine kinase of a two-
component signal transduction system that partners with the
YycF response regulator. YycFG functions as a master regulatory
system for cell wall metabolism and bioﬁlm formation and is
the only two-component system required for viability in many
Gram-positive bacteria (Winkler and Hoch, 2008; Baltz, 2009).
Comparative Proteomic Analyses of
Methicillin, Vancomycin, Linezolid, and
Daptomycin Resistance
Quantitative proteomics have been considerably improved
during the past decade and have been employed for investigation
of the diﬀerences in whole protein expression dynamics of cells
grown under a variety of growth conditions or stress conditions
such as antibiotics (Radhouani et al., 2012). Therefore, by studies
using quantitative proteomic approaches in the past few years,
a considerable progress has recently been made in the study of
antibiotic resistancemechanism. To summarize recent updates to
understand the resistancemechanism to four clinically important
antibiotics used in the treatment of Gram-positive pathogens,
we used the Preferred Reporting Items for Systematic Review
and Meta-Analysis (PRISMA) in our review (Figure 1) (Moher
et al., 2009). We conducted a systematic literature search in
the following databases: Medline via PubMed and Embase. We
used keywords as search terms. We combined terms for selected
indications (methicillin, vancomycin, linezolid, daptomycin, and
proteomics). The literature search included all studies published
in English between 2000 and 2015. We identiﬁed 13 proteomics
studies comparing proteomic proﬁles in antibiotic-resistant and
antibiotic-sensitive strains or exploring proteomic proﬁles in cells
treated with or without antibiotics.
Methicillin
Two studies exploring proteomic proﬁles of methicillin-
susceptible S. aureus (MSSA) and methicillin-resistant S. aureus
(MRSA) in the absence of methicillin were reported (Cordwell
et al., 2002; Enany et al., 2014). Cordwell et al. compared the
protein proﬁles between S. aureus strains COL (methicillin-
resistant) and 8325 (methicillin-susceptible) in the absence of
methicillin (Cordwell et al., 2002). Interestingly, among proteins
previously known as resistance-related factors (e.g.,mecA, glmM,
fmtAB, murE, llm, bla, and fem factors), only FemA protein,
which is known as a host-mediated factor essential for methicillin
resistance in S. aureus (Berger-Bächi et al., 1989), was more
highly expressed in methicillin-resistant cells (Cordwell et al.,
2002). However, upon growth of both strains in the presence
of Triton X-100 (TX-100), a detergent that has been shown to
reduce methicillin resistance, no diﬀerence on the production
of the essential methicillin-resistance factor FemA was detected
(Cordwell et al., 2002). Instead, expression levels of stress-
related proteins including cold-shock proteins (CspABC) and
alkaline-shock protein 23 (Asp23) increased in the methicillin-
resistant S. aureus strain COL (Cordwell et al., 2002). Notably,
the amount of CspB, CspC, and Asp23 proteins was aﬀected
in cases of vancomycin and daptomycin antibiotics, despite
being down-regulated in the vancomycin-resistant strain and
up-regulated in the daptomycin-resistant strain (Table 7). This
study also showed that three proteins linked to the alternative
FIGURE 1 | Literature selection process (PRISMA flow diagram).
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sigma factor σB, Asp23, anti-anti- σB factor RsbV, and conserved
hypothetical protein SA0772, were also present at signiﬁcantly
higher levels in methicillin-resistant cells (Cordwell et al., 2002).
In the presence of TX-100 weakening the methicillin resistance,
the comparative proteomic analysis showed that proteins of
the σB and SarA (a regulator of virulence genes) regulons are
involved in methicillin resistance of S. aureus (Cordwell et al.,
2002). The level of SarA protein also increased in vancomycin-
resistant and daptomycin-resistant cells (Table 7). This study
also showed that the stage V sporulation protein G (SpoVG),
originally identiﬁed in Bacillus subtilis as being involved in the
formation of the spore cortex (Matsuno and Sonenshein, 1999),
was up-regulated in the methicillin-resistant S. aureus strain
COL. In the non-sporulating S. aureus, SpoVG contributes to
stimulate capsule synthesis, and was recently shown to regulate
a small σB-subregulon comprising mainly excreted virulence
factors including the highly up-regulated virulence factor EsxA
(Schulthess et al., 2012). Recently, it has been reported that
SpoVGwas involved in resistance mechanisms to methicillin and
glycopeptide (Schulthess et al., 2009). Together with this report,
a comparative proteome analysis showed that the expression
level of SpoVG increased in strains resistant to methicillin,
vancomycin, and daptomycin (Table 5), indicating that SpoVG
may be involved in resistance mechanisms to other antibiotics as
well as methicillin and glycopeptide.
Another report explored proteome proﬁles of extracellular
proteins in methicillin-sensitive and methicillin-resistant S.
aureus (Enany et al., 2014). They identiﬁed some proteins
increased in MRSA; Asp23 (10-fold more in MRSA than
MSSA), alkyl hydroperoxide reductase subunit C (AhpC) (2-
fold), D-lactate dehydrogenase (LdhD) (2-fold), general stress
protein 20U (3-fold), L-lactate dehydrogenase (LdhA) (2-fold),
pyruvate dehydrogenase E1 component beta subunit (PdhB) (2-
fold), superoxide dismutase (SodA) (2-fold), triacylglycerol lipase
precursor (LipA) (2-fold), triosephosphate isomerase (TpiA)
(2-fold), and universal stress protein family protein (7-fold)
(Enany et al., 2014). Notably, among them, most proteins (AhpC,
SodA, LdhA, LipA, and TipA) also have altered expression
levels in other antibiotic-resistant strains (Table 7). In addition,
elongation factor G (encoded by the fusA gene) was also increased
in MRSA. Our analysis showed that PusA is one of the three
proteins aﬀected in all four antibiotic-resistant strains (Table 5).
Although elongation factor G is a major target of fusidic acid
which has been used as a topical agent for skin infection and
for some systemic infections caused by S. aureus (Howden
and Grayson, 2006), and had a contribution to fusidic acid
resistance mechanisms evolved in MRSA (Koripella et al., 2012),
the relationship between elongation factor G and resistance
mechanisms of other antibiotics has not yet been identiﬁed.
Vancomycin
There were two studies exploring proteomic proﬁles in
vancomycin-susceptible S. aureus (VSSA) and vancomycin-
intermediate S. aureus (VISA) with a minimal inhibitory
concentration (MIC) of 4–8μg/ml, one study exploring
proteomic proﬁles in VSSA and heterogeneous vancomycin-
intermediate S. aureus (hVISA) with a vancomycin MIC
of ≤2μg/ml, one study exploring proteomic proﬁles in
VISA and vancomycin-resistant S. aureus (VRSA) with
MIC of ≥8μg/ml, one study analyzing global proteomes of
vancomycin stress in S. aureus, and two studies examining
vancomycin-induced proteomes of Enterococcus faecalis
under vancomycin treatment (Pieper et al., 2006; Scherl et al.,
2006; Drummelsmith et al., 2007; Wang et al., 2010; Chen
et al., 2013; Hessling et al., 2013; Ramos et al., 2015).
Many proteins previously known as resistance-related factors,
including VanA, VanB, VanX, and VanR, were also identiﬁed
in comparative proteomic analyses (Table 2). Scherl et al.
(2006) showed that a total of 155 proteins are diﬀerentially
expressed between two vancomycin-susceptible S. aureus strains
(MRGR3 and 14-4Rev) and the vancomycin-intermediate
S. aureus strain 14-4, and most proteins play a role in
energy metabolism, cell envelope biosynthesis, protein turnover,
amino acids transport, and metabolism, and inorganic ion
transport. Genes or gene products known to be involved
in resistance mechanisms to diﬀerent antibiotics, such as
PBP 2a (MecA), O-nucleotidyltransferase(9) [Ant(9)], UDP-
N-acetylmuramyl tripeptide synthetase (MurE), and penicillin-
binding methicillin resistant-related protein (FmtA), were up-
regulated in the VISA strain (Scherl et al., 2006). All of them
are involved in peptidoglycan biosynthesis. Levels of many other
proteins involved in peptidoglycan metabolism also increased in
the VISA strain, such as glycosyltransferase (SgtB) and CHAP
TABLE 2 | Differentially expressed proteins identified by the quantitative proteomic approach: proteins involved in resistance mechanisms.
Biological process Protein name Gene Antibiotics Regulation Frequency
of difference
References Protein description
Antibiotic inactivation Bleomycin resistance protein ble Van Down 1 Pieper et al., 2006 Inhibition of bleomycin by
a direct interaction
Kanamycin nucleotidyltransferase knt Van Down 1 Pieper et al., 2006 Modification of kanamycin
Vancomycin resistance protein vanA Van Up 2 Wang et al., 2010;
Ramos et al., 2015
Alteration of the
D-Ala-D-Ala dipeptide
O-nucleotidyltransferase (9) ant(9) Van Up 1 Scherl et al., 2006 Modification of
vancomycin
Tables 2–8 : Met, methicillin; Van, vancomycin; Lin, linezolid; Dap, daptomycin; up, up-regulated in antibiotic-resistant strain or under antibiotic treatment; down, down-regulated in
antibiotic-resistant strain or under antibiotic treatment.
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domain amidase (SsaA). SsaA belongs to the CHAP amidase
family, members of which such as LysK and LytA have been
shown to have D-alanyl-glycyl endopeptidase activity, cleaving
between the crossbridge and the stem peptide (Delaune et al.,
2011), and protein levels of SsaA were also changed in cases
of methicillin and linezolid (Table 6), indicating the importance
of this protein on peptidoglycan metabolism and antibiotic
resistance.
They also identiﬁed several regulatory systems contributing
to the VISA phenotype, such as the two-component system
(VraSR) regulating expression of a set of genes involved in
the cell wall biosynthesis or degradation (Boyle-Vavra et al.,
2013), the signal transduction protein TRAP acting on quorum
sensing (Gov et al., 2004), the DivIVA protein known to
regulate cell division in B. subtilis (Perry and Edwards, 2004),
and putative transcription factors SA2296 and SarH1. VraSR
(vancomycin resistance associated regulator) was up-regulated
under vancomycin treatment (Kuroda et al., 2003) and in the
VISA strain when compared with an isogenic vancomycin-
susceptible strain (Kuroda et al., 2000). In addition, inactivation
of the vraSR gene increased vancomycin susceptibility (Kuroda
et al., 2003). Interestingly, VraSR was also induced by other
antibiotic classes that target the cell wall, including β-lactam
(Gardete et al., 2006; Yin et al., 2006), mersacidin (Sass
et al., 2008), certain cationic peptides (Pietiäinen et al., 2009),
and daptomycin (Muthaiyan et al., 2008). Inactivation of the
vraSR gene attenuates resistance to various antibiotics, such
as vancomycin (Kuroda et al., 2003; Gardete et al., 2006),
daptomycin (Mehta et al., 2012), and β-lactams (Kuroda et al.,
2003; Boyle-Vavra et al., 2006; Gardete et al., 2006). The
expression of many genes, such as ctpA, drp35, fmtA, opuD,
pbp2, prsA, sgtB, and vraX, is regulated by VraSR (Utaida
et al., 2003; McAleese et al., 2006; Dengler et al., 2011).
Among them, FmtA is typically known as a factor involved
in methicillin-resistant phenotype of S. aureus (Fan et al.,
2007), and PrsA (foldase precursor) was recently reported to
be involved in both glycopeptide and oxacillin resistance in S.
aureus (Jousselin et al., 2012). Similarly, at three independent
studies of comparative proteomic analysis, it has been proven
that the expression level of PrsA is up-regulated in VISA
when compared with VSSA (Table 5), indicating that proteomic
studies can support the identiﬁcation of targets involved in
antibiotic resistance. They also identiﬁed another important
protein VraX (a hypothetical protein which encodes a 55-amino
acids protein) diﬀerentially expressed between vancomycin-
susceptible S. aureus strains and the vancomycin-intermediate
S. aureus strain 14-4 (Scherl et al., 2006). This gene was
up-regulated by multiple cell wall and/or membrane active
compounds (bacitracin, d-cycloserine, oxacillin, tunicamycin,
ﬂavomycin, fosfomycin, teicoplanin, vancomycin, daptomycin,
lysostaphin, epicatechin gallate, ranalexin, and antimicrobial
peptides) (Utaida et al., 2003; Pietiäinen et al., 2009; Dengler
et al., 2011; Cuaron et al., 2013). The vraX gene belongs to
the vra operon together with the vraA gene encoding for a
long chain fatty acid-CoA ligase, which was up-regulated in the
VISA. Additionally, this gene seems to be involved in resistance
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mechanism to vancomycin (Hanaki et al., 1998; Buntaran et al.,
2013). Finally, stress-related proteins such as proteinases (CtpA),
methionine sulfoxide reductase A (MsrA2), and the methionine
sulfoxide reductase regulator MsrR, were over-expressed in the
vancomycin-intermediate S. aureus strain 14-4 (Scherl et al.,
2006). In other studies, MsrA2 was also up-regulated in hVISA
(Chen et al., 2013).
Pieper et al. showed that purine ribonucleotide biosynthesis
(PRNBS) pathway enzymes, which are under the control of the
PurR regulator, strongly increased in protein abundance in the
vancomycin-resistant S. aureus strain VP32 having a vancomycin
MIC of 32μg/ml when compared with the vancomycin-
intermediate S. aureus strain HIP5827 (MIC = 8μg/ml) (Pieper
et al., 2006). Notably, among them, several proteins such as
amidophosphoribosyltransferase (PurF), phosphoribosylamine-
glycine ligase (PurD), phosphoribosylglycinamidine cyclo-ligase
(PurM), phosphoribosylaminoimidazole-succinocarboxamide
synthase (PurC), adenylosuccinate lyase (PurB), and bifunctional
purine biosynthesis protein (PurH), were also changed in protein
abundance in cases of other antibiotics such as daptomycin and
linezolid (Table 4). Microarray transcription analysis of clinical
VISA isolates already showed that among the 35 genes with
increased transcription in vancomycin-resistant S. aureus strain
VP32 when compared with those of their VISA parent strains
HIP5827 and P100, 15 were involved in purine biosynthesis
or transport (Mongodin et al., 2003). They hypothesized that
increased energy (ATP) is required to generate the thicker
cell walls that characterize resistant mutants (Mongodin et al.,
2003). However, contrary to these results, other comparative
proteomic analyses between vancomycin-susceptible strains and
vancomycin-intermediate S. aureus strains did not show similar
results (Scherl et al., 2006; Drummelsmith et al., 2007; Chen
et al., 2013). Therefore, these results imply that VRSA may more
eﬃciently compensate for a ﬁtness cost of antibiotic resistance
such as ATP requirement than VISA.
Abundance changes were also found in proteins such as
the single-stranded DNA binding protein (TraM), DNA gyrase
subunit B (GyrB), and topoisomerase IV subunit B (ParE), which
catalyze or inﬂuence the ﬁdelity of DNA replication and repair
(Table 5). This result is consistent with the increasing evidence
that exposure to antibiotics in bacteria leads to increased
mutation rates in the genome, to favor their survivals under
antibiotic pressure (Napolitano et al., 2000; Friedberg et al., 2002;
Pieper et al., 2006). Expression levels of many enzymes involved
in energy metabolisms, including L-lactate dehydrogenase
(LdhA), glucose-6-phosphate isomerase (Pgi), succinyl-CoA
synthetase (SucCD), phosphoglycerate kinase (Pgk), nitrate
reductase alpha chain (NarG), and aconitate hydratase (CitB),
were also changed. In fact, comparative proteomic analyses show
that proteins involved in energy metabolism, protein synthesis,
and envelope biogenesis, most frequently exhibit abundance
change in antibiotic-resistant strains (Table 3). In many cases,
proteins playing a role in energy metabolism were up-regulated
in antibiotic-resistant strains (Table 3). This phenomenon may
be explained by a prior hypothesis that increased energy (ATP)
is required to generate the thicker cell walls or to pump
antibiotics out of the cell using eﬄux pumps. This study
also showed the changes of proteins involved in cell envelope
biogenesis, such as D-Ala-D-Ala ligase (Ddl), D-Ala-D-Lac
ligase (VanA), peptidoglycan hydrolase (LytM), cell division
and cell wall biosynthesis protein (MraZ), putative cell wall
transglycosylase (SceD), and glucosamine-fructose-6-phosphate
aminotransferase (GlmS) (Pieper et al., 2006).
Similar to prior reports, Drummelsmith et al. showed the high
level inductions of cell wall metabolism-related proteins such as
MecA, LytM, GlmS, and SceD in the VISA type strain Mu50
when compared with the vancomycin-sensitive strain CMRSA-2
(Drummelsmith et al., 2007). In particular, they selected SceD for
further study based on its high level of induction (approximately
16-fold) in VISA, and relative sceD mRNA expression levels
were compared between 25VSSA and VISA clinical isolates
by real-time RT-PCR (Drummelsmith et al., 2007). The sceD
mRNA was signiﬁcantly induced in all VISA isolates relative to
all VSSA strains, and they suggest that SceD expression level
could serve as a molecular diagnostic marker for the rapid
detection of VISA (Drummelsmith et al., 2007). Interestingly,
SceD was also up-regulated in both daptomycin-resistant (Song
et al., 2013) and linezolid-resistant strains (Bernardo et al.,
2004), suggesting the importance of this protein in antibiotic
resistance. They also identiﬁed other proteins involved in cell
envelope metabolism as a highly up-regulated protein in VISA;
UDP-GlcNAc 1-carboxyvinyltransferase 1 (MurA), bifunctional
autolysin (Atl), immunodominant antigen A (IsaA), UDP-
glucose/GDP-mannose dehydrogenase (CapO), and UDP-N-
acetyltalosamine 2-epimerase (CapG) (Table 6). Among them,
IsaA was also up-regulated in VISA at other two studies (Scherl
et al., 2006; Chen et al., 2013). In addition, its expression level
increased in both methicillin-resistant and daptomycin-resistant
strains (Cordwell et al., 2002; Fischer et al., 2011), and decreased
in linezolid-resistant strains (Bernardo et al., 2004), suggesting
the importance of this protein. The housekeeping protein
IsaA is a highly immunogenic, non-covalently cell wall-bound
lytic transglycosylase that is co-regulated with a glycylglycine
endopeptidase LytM (Stapleton et al., 2007; Lorenz et al., 2011).
S. aureus has two putative peptidoglycan hydrolases, IsaA and
SceD, and SceD can compensate for the loss of IsaA (Stapleton
et al., 2007). The fact that both peptidoglycan hydrolases (IsaA
and SceD) are involved in antibiotic resistance strongly indicates
the importance of cell wall dynamics in antibiotic resistance
mechanism.
To identify the resistance mechanisms of hVISA with a
vancomycin MIC of ≤2μg/ml, Chen et al. compared proteomic
proﬁles of six pairs of isogenic hVISA and VSSA strains and
unrelated hVISA (n = 24) and VSSA stains (n = 30) (Chen et al.,
2013). They identiﬁed ﬁve proteins up-regulated in the hVISA
strains; IsaA, MsrA, Asp32, 2,3-bisphosphoglycerate-dependent
phosphoglycerate mutase (GpmA), and AhpC. Consistent with
this result, MsrA was up-regulated in a prior study using
comparative proteomics (Scherl et al., 2006) and in the DNA
microarray study, and the msrA gene was also over-expressed in
VISA strains (Cui et al., 2005). MsrA, catalyzing the reversible
oxidation-reduction of methionine sulfoxide to methionine, has
a key function as a repair enzyme for proteins inactivated
by oxidation (Chen et al., 2013). The msrA gene is highly
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induced by cell wall-active antibiotics, such as oxacillin and
vancomycin (Chen et al., 2013). The increased level of MsrA
can enhance peptidoglycan biosynthesis which results in cell
wall thickening, and gene knockout of the msrA gene weakened
vancomycin and β-lactam resistance of S. aureus strains (Cui
et al., 2005). In addition, MsrA is involved in virulence in
several bacteria (Sasindran et al., 2007). Taken together, these
observations suggest the important role of methionine sulfoxide
in antibiotic resistance. Although in other studies, the abundance
of GpmA, which plays a physiological role in glycolysis, has
been reported to be changed in VISA (Table 3), its exact role
in antibiotic resistance has not been determined. AhpC, an
alkyl hydroperoxide reductase subunit C, plays an important
role in oxidative-stress resistance of S. aureus (Cosgrove et al.,
2007). Interestingly, it was reported that AhpC is up-regulated
in strains resistant to methicillin, vancomycin, and daptomycin
antibiotics (Table 7). However, up to now, there is no report
investigating the direct role of AhpC in antibiotic resistance. It
is noteworthy that several proteins involved in oxidative-stress
resistance, such as AhpC, SodA, catalase (KatA), and superoxide
dismutase (SodM), show the abundance change of proteins in
antibiotic-resistant strains (Table 7), and in most cases, their
expression is up-regulated. In spite of these interesting results,
the relationship between these proteins and antibiotic resistance
was not determined.
Hassling et al. analyzed proteomic proﬁles of vancomycin-
susceptible S. aureus strain COL under the sublethal vancomycin
exposure (4.5μg/ml) (Hessling et al., 2013). They found the
speciﬁc increase of proteins involved in the synthesis of lysine
which are essential for the synthesis of the peptidoglycan
precursor pentapeptide; aspartate kinase (LysC), aspartate
semialdehyde dehydrogenase (Asd), dihydrodipicolinate
synthase (DapA), 4-hydroxy-tetrahydrodipicolinate reductase
(DapB), diaminopimelate decarboxylase (LysA), and
tetrahydrodipicolinate acetyltransferase (DapD). An increase
of lysine synthesis proteins can lead to an overall increase of
peptidoglycan synthesis. Induction of genes involved in lysine
synthesis under cell wall stress conditions have been documented
before by two transcriptome studies (Kuroda et al., 2003; Sobral
et al., 2007). Consistent with the previous report (Scherl et al.,
2006), this report also showed that several proteins regulated by
the two-component system VraSR increased in amount after
vancomycin addition (Hessling et al., 2013). Additionally, they
identiﬁed two important regulators (the alternative sigma factor
σB and the two-component system SaeRS regulating numerous
virulence genes) that play a role in vancomycin stress response.
The cluster of proteins under positive σB control mainly
increased, whereas negatively regulated proteins primarily
decreased in amount after vancomycin addition (Hessling et al.,
2013). The induction of σB regulon by vancomycin has been
found in another report (Chen et al., 2013). Increase of the σB
activity has also been observed in strains resistant to teicoplanin
(Bischoﬀ and Berger-Bächi, 2001) or methicillin (Cordwell et al.,
2002). Hassling et al. also found decreased expression levels of
most proteins with a virulence related function (Hessling et al.,
2013). However, because the great majority of virulence genes in
previous transcriptome studies under cell wall stress in S. aureus
have been shown to be up-regulated (Kuroda et al., 2003; Utaida
et al., 2003; Sobral et al., 2007), the role of virulence genes in
antibiotic resistance needs to be determined.
Lastly, Wang et al. and Ramos et al. performed proteomic
analysis of vancomycin-resistant E. faecalis strains (V583, V306,
and SU18) under 64μg/ml vancomycin treatment (Wang et al.,
2010; Ramos et al., 2015). Vancomycin induced expression of
vancomycin resistance-related proteins such as VanA, VanX,
D-Ala-D-Ala dipeptidase (DdpX), VanR, and VanB (Wang
et al., 2010; Ramos et al., 2015). Distinctively, Wang et al.
found that six proteins (Pgm, Ldh, Gap-2, RpsB, EF2076,
and sex pheromone cAD1 precursor lipoprotein) exhibited
clear post-translational modiﬁcations and vancomycin induced
phosphorylation of Ser/Thr in Ldh, Gap-2, and sex pheromone
cAD1 precursor lipoprotein (EF3256) (Wang et al., 2010).
Ramos et al. showed that metabolism-related proteins, such as
TipA, GMP synthase (GuaA), and glyceraldehyde-3-phosphate
dehydrogenase (GapB), were down-regulated under vancomycin
treatment (Ramos et al., 2015).
Linezolid
There was one study exploring comparative proteomic proﬁles
in linezolid-susceptible S. pneumonia strains and linezolid-
resistant S. pneumonia strains, and one study analyzing global
proteomes of a linezolid- susceptible S. aureus under linezolid
stresses (Bernardo et al., 2004; Feng et al., 2011). Through
the comparison between linezolid-susceptible S. pneumonia
strains (1974 and R6) with linezolid MICs of 0.5–0.75μg/ml
and linezolid-resistant S. pneumonia strains (1974M2-LZD and
R6M2-LZD) with MIC of 32μg/ml, Feng et al. showed that the
proteomic and transcriptomic approaches were poorly correlated
with previously known resistance factors (23S rRNA, ribosomal
proteins L3 and L4, RNA methyltransferase Cfr, and ABC
transporter PatA and PatB), as modulated proteins rarely had
signiﬁcant concomitant changes at the expression level (Feng
et al., 2011). They found increased expression of proteins
involved in the metabolism and transport of carbohydrates in
linezolid-resistant S. pneumoniae strains (Feng et al., 2011).
Through inactivation of target genes in the linezolid-resistant
strains (1974M2-LZD and R6M2-LZD), they identiﬁed two ABC
transporter substrate-binding proteins (Spr0083 and Spr1527)
and the catabolite control protein A (CcpA) as factors associated
with resistance to linezolid (Feng et al., 2011). CcpA is known
to function as the global regulator controlling the eﬃcient
utilization of sugars through carbon catabolite repression (CCR)
in Gram-positive bacteria (Stülke and Hillen, 2000). Inactivation
of the ccpA gene in S. aureus aﬀected growth, glucosemetabolism,
and expression of virulence genes (Seidl et al., 2006). CcpA
inactivation was also linked to the down-regulation of glycolytic
genes in Bacillus cereus (van der Voort et al., 2008; Feng et al.,
2011). Therefore, the increased level of CcpA may cause the
increased expression of glycolytic enzymes in linezolid-resistant
S. pneumonia strains. In S. aureus, the correlation between
antibiotic resistance and CcpA has already been reported, as
CcpA inactivation signiﬁcantly reduced the oxacillin resistance
levels in MRSA and the teicoplanin resistance level in a
glycopeptide-intermediate-resistant S. aureus strain (Seidl et al.,
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2006). Table 3 shows the possibility that CcpA may also be
involved in methicillin and vancomycin resistance. Together
with CcpA, inactivation of two ABC transporters putatively
involved in the sugar transport (Spr0083 and Spr1527) also
reduced resistance to linezolid of S. pneumonia (Feng et al., 2011).
Notably, S. pneumoniae is predicted to be highly dependent on
external sugars to fulﬁll its energy requirements by substrate-level
phosphorylation as it lacks functional electron transport chain
and tricarboxylic acid cycle (Tettelin et al., 2001; Feng et al.,
2011). This process eventually leads to the formation of lactate
and acetate by the lactate dehydrogenase and lactate oxidase
enzymes and these proteins were also found to be overexpressed
in linezolid-resistant S. pneumonia strains (Tettelin et al., 2001;
Feng et al., 2011). Therefore, these results imply increased
energy requirements associated with resistance mechanism to
linezolid in S. pneumonia (Feng et al., 2011). To sustain a
ﬁtness cost associated with resistance mechanisms such as the
23S rRNA mutations (Besier et al., 2008), S. pneumonia seems
to select an increased metabolism of sugars as a secondary
adaptation.
This study also showed that several genes involved
in the biosynthesis of fatty acids, including enoyl-CoA
hydratase (PhaB), 3-ketoacyl-ACP reductase (FabG), acetyl-
CoA carboxylase biotin carboxyl carrier protein subunit
(AccB), acetyl-CoA carboxylase subunit alpha (AccA), and
hydroxymyristoyl-ACP dehydratase (FabZ), were down-
regulated in linezolid-resistant strains (Feng et al., 2011).
Whether this is directly related to linezolid resistance remains
to be established, but it is intriguing that the cell wall inhibitor
penicillin also causes a down-regulation of several genes of this
pathway in S. pneumoniae (Rogers et al., 2007; Feng et al., 2011).
Interestingly, expression levels of FabZ are changed in all cases
of the four antibiotics (Table 6), even though its expression
increased in methicillin-resistant strains and decreased in strains
resistant to other antibiotics. Many numbers of ribosomal
proteins were found to be overexpressed or down-regulated in
linezolid-resistant strains, but whether this pattern is due to the
mechanism of action of linezolid (which targets the ribosome)
remains to be established. Although recent several lines of
evidence indicate the presence of functional selective ribosomal
subpopulations that exhibit variations in the RNA or the protein
components and modulate the translational program in response
to environmental changes (Byrgazov et al., 2013), it is diﬃcult
to obtain any information from variation patterns of ribosomal
proteins in this study.
Bernardo et al. compared the change of proteomic proﬁles of
a linezolid- susceptible S. aureus strain ATCC 29213 (MIC =
2.5μg/ml) under linezolid stresses (12.5, 25, 50, and 90% of
MIC) (Bernardo et al., 2004). They found that linezolid reduced
in a dose-dependent manner the secretion of speciﬁc virulence
factors, including bifunctional autolysin (Atl), immunoglobulin
G binding protein A (Spa), and α-hemolysin (SAV1163), CHAP-
domain amidase (SsaA), and immunodominant antigen A
(IsaA). This result is similar to the proteomic result that analyzes
protein proﬁles of S. aureus under the sublethal vancomycin
exposure (Hessling et al., 2013).
Daptomycin
There were one study examining comparative proteomic
proﬁles in daptomycin-susceptible and daptomycin-resistant
S. aureus strains, and one study analyzing global proteomes
of daptomycin-susceptible B. subtilis under daptomycin stress
(Wecke et al., 2009; Fischer et al., 2011). Unlike other three
antibiotics (methicillin, vancomycin, and linezolid), speciﬁc
genetic determinant of the daptomycin-resistant strain was not
determined. Probable daptomycin resistance-related proteins
(MprF, YycG, RpoB, and RpoC) identiﬁed in previous reports
(Jones et al., 2008; Baltz, 2009) were not identiﬁed in
comparative proteomic analyses (Tables 2–8). In 2011, Fisher
et al. compared proteomic proﬁles in the daptomycin-susceptible
S. aureus strain 616 with a daptomycin MIC of 0.5μg/ml
and the daptomycin-resistant S. aureus strain 701 with MIC
of 2μg/ml (Fischer et al., 2011). Comparative proteomics and
transcriptomic approach revealed a diﬀerential abundance of
proteins in various functional categories, including cell wall-
associated targets and bioﬁlm formation proteins (Fischer
et al., 2011). Phenotypically, daptomycin-susceptible strains, and
daptomycin-resistant strains showed major diﬀerences in their
ability to develop bacterial bioﬁlms in the presence of the
antibacterial lipid, oleic acid (Fischer et al., 2011). Transcriptomic
approach showed diﬀerent expressions of some important genes,
such as the key genes (yycFGHI) aﬀecting cell membrane
lipid homeostasis, cell wall metabolism and bioﬁlm formation,
and two-component regulation system genes (agr, saeRS, and
vraRS) involved in pathogenesis of methicillin-resistant strains
(Fischer et al., 2011). However, through proteomic research,
only several proteins, including Asp23, 3-oxoacyl-ACP synthase
II (FabF), GTP-sensing transcriptional pleiotropic repressor
(CodY), and PurH, was identiﬁed as proteins involved in
daptomycin resistance.
Wecke et al. searched proteins induced by daptomycin,
through the proteomic approach of a daptomycin-susceptible B.
subtilis strain W168 under daptomycin treatment of sublethal
amount (1μg/ml) (Wecke et al., 2009). They identiﬁed LiaI
and LiaH proteins exclusively and strongly induced (429-fold)
by daptomycin. This result is in good agreement with data
analyzing genes induced by daptomycin through transcriptome
proﬁling (Muthaiyan et al., 2008). LiaH is a conserved membrane
protein similar to a phage shock protein A (PspA) of E. coli,
and its expression is regulated by the cell envelope stress-
sensing two-component system LiaRS (Jordan et al., 2006;
Hachmann et al., 2009; Wecke et al., 2009). Inactivation of
liaH leads to 3-fold increased susceptibility to daptomycin and
this susceptibility was further exacerbated in cells additionally
lacking the paralogous gene pspA (Hachmann et al., 2009).
In E. coli, the pspA gene is induced upon phage infection,
osmotic shock, exposure to ethanol, or temperature increase, and
functions to help cells manage the impacts of agents impairing
cell membrane function (Joly et al., 2010). A recent report
showed that deletion of the response regulator LiaR regulating
expression of liaIH in daptomycin-resistant E. faecalis reversed
resistance to daptomycin, and resulted in hypersusceptibility to
daptomycin (Reyes et al., 2015). Therefore, these results indicate
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that LiaR is a master regulator protecting cell membrane to
diverse antimicrobial agents, through regulating expression of
various genes such as the liaH gene (Reyes et al., 2015).
Conclusion
Although speciﬁc genetic determinants of resistance mechanisms
to methicillin, vancomycin, and linezolid were identiﬁed through
non-proteomic approaches (e.g., van genes in vancomycin
resistance) (Table 1), recent comparative proteomic methods
provide new opportunities to understand the antibiotic resistance
mechanism. In particular, in the case of recently used antibiotics
such as daptomycin, speciﬁc genetic determinant(s) of antibiotic
resistance was not fully determined through non-proteomic
approaches. Therefore, quantitative proteomic methods can
be a good tool to ﬁnd an important protein involved in
daptomycin resistance. Actually, a proteomic research identiﬁed
LiaH as a highly induced protein by daptomycin treatment
(Muthaiyan et al., 2008) and a subsequent report showed that
the expression level of this protein is important to daptomycin-
resistant phenotype (Reyes et al., 2015). These results show that
quantitative proteomic analysis can be used as an eﬀective tool to
ﬁnd novel resistance mechanisms.
Interestingly, comparative proteomic approaches in
methicillin, linezolid, and daptomycin, except for vancomycin,
were poorly correlated with known resistance-related factors
found by non-proteomic approaches (Table 2). This result
may be caused by a lack of comparative proteomic studies in
three antibiotics, or imply the existence of novel resistance
mechanisms diﬀerent from previously known resistance
mechanisms found by non-proteomic approaches. Through
summarizing recent data of comparative proteomic researches
of four clinically important antibiotics, we can ﬁnd proteins
of which expression levels are changed only in the resistance
mechanism to speciﬁc antibiotic, such as LiaH in daptomycin
resistance and PrsA in vancomycin resistance. It is necessary
to determine whether these proteins aﬀect antibiotic resistance
through regulating previously known resistance-related
determinants or by a novel mechanism. Another interesting
result is that many proteins identiﬁed by comparative proteomic
analyses seem to be simultaneously involved in resistance
mechanism to two or more antibiotics (Tables 2–8). These
proteins include cold shock proteins (CspABC), sporulation
protein G (SpoVG), alkyl hydroperoxide reductase subunit
C (AhpC), L-lactate dehydrogenase (LdhA), triacylglycerol
lipase precursor (LipA), superoxide dismutase (SodA), catalase
(KatA), elongation factor G (FusA), CHAP-domain amidase
(SsaA), two component system (VraSR), penicillin binding
methicillin resistant-related protein (FmtA), adenylosuccinate
lyase (PurB), glucose-6-phosphate isomerase (Pgi), catabolite
control protein A (CcpA), putative cell wall transglycosylase
(SceD), immunodominant antigen A (IsaA), bifunctional
autolysin (Atl), the σB regulon, and hydroxymyristoyl-ACP
dehydratase (FabZ). These proteins can be divided into two
groups, proteins involved in bacterial envelope regulation and
proteins compensating for a ﬁtness cost of antibiotic resistance.
Proteins such as LipA, VraSR, FmtA, SsaA, SceD, IsaA, Atl,
and FabZ, are directly or indirectly involved in envelope
regulation. In order to modify or thicken the bacterial cell
wall for antibiotic resistance, cells require abundant energy,
and proteins involved in stress adaptation are necessary to
neutralize various damages by antibiotic. To sustain these ﬁtness
costs associated with resistance mechanisms, proteins involved
in energy metabolism (LdhA, FusA, Pgi, PurB, and CcpA)
and stress-related proteins (CspABC, SpoVG, AhpC, SodA,
KatA, and the σB regulon) seem to be identiﬁed in resistance
mechanisms to several antibiotics. Therefore, these proteomic
results conﬁrm that antibiotic resistance requires a ﬁtness
cost.
Detailed studies on the mechanism by which these proteins
aﬀect antibiotic resistance are required. In particular, because
these proteins can act as the global factor aﬀecting resistance
mechanisms to most antibiotics, it is necessary to examine
whether they aﬀect resistance mechanism of other antibiotics
having diﬀerent action modes. These studies will provide
important clues for understanding and managing antibiotic
resistance.
Acknowledgments
This study was supported by the National Research Laboratory
Program through the National Research Foundation of Korea
(NRF) funded by the Ministry of Science, ICT and Future
Planning (No. 2011-0027928); the Cooperative Research
Program for Agriculture Science and Technology Development
(No. PJ01103103) of Rural Development Administration in
Republic of Korea; and the National Research Foundation of the
Ministry of Education, Republic of Korea (2012R1A1A2044184).
References
Ament, P. W., Jamshed, N., and Horne, J. P. (2002). Linezolid: its role in
the treatment of gram-positive, drug-resistant bacterial infections. Am. Fam.
Physician. 65, 663–671. Available online at: http://www.aafp.org/afp/2002/
0215/p663.html
Baltz, R. H. (2009). Daptomycin: mechanisms of action and resistance,
and biosynthetic engineering. Curr. Opin. Chem. Biol. 13, 144–151. doi:
10.1016/j.cbpa.2009.02.031
Berger-Bächi, B., Barberis-Maino, L., Strässle, A., and Kayser, F. H. (1989). FemA,
a host-mediated factor essential for methicillin resistance in Staphylococcus
aureus: molecular cloning and characterization. Mol. Gen. Genet. 219,
263–269.
Bernardo, K., Pakulat, N., Fleer, S., Schnaith, A., Utermöhlen, O.,
Krut, O., et al. (2004). Subinhibitory concentrations of linezolid
reduce Staphylococcus aureus virulence factor expression. Antimicrob.
Agents Chemother. 48, 546–555. doi: 10.1128/AAC.48.2.546-
555.2004
Besier, S., Ludwig, A., Zander, J., Brade, V., andWichelhaus, T. A. (2008). Linezolid
resistance in Staphylococcus aureus: gene dosage eﬀect, stability, ﬁtness costs,
and cross-resistances. Antimicrob. Agents Chemother. 52, 1570–1572. doi:
10.1128/AAC.01098-07
Frontiers in Microbiology | www.frontiersin.org 26 August 2015 | Volume 6 | Article 828
Lee et al. Proteomic approach of antibiotic resistance
Bischoﬀ, M., and Berger-Bächi, B. (2001). Teicoplanin stress-selected mutations
increasing σB activity in Staphylococcus aureus. Antimicrob. Agents Chemother.
45, 1714–1720. doi: 10.1128/AAC.45.6.1714-1720.2001
Boyle-Vavra, S., Yin, S., and Daum, R. S. (2006). The VraS/VraR two-
component regulatory system required for oxacillin resistance in community-
acquired methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett.
262, 163–171. doi: 10.1111/j.1574-6968.2006.00384.x
Boyle-Vavra, S., Yin, S., Jo, D. S., Montgomery, C. P., and Daum, R. S. (2013).
VraT/YvqF is required for methicillin resistance and activation of the VraSR
regulon in Staphylococcus aureus. Antimicrob. Agents Chemother. 57, 83–95.
doi: 10.1128/AAC.01651-12
Buntaran, L., Hatta, M., Sultan, A. R., Dwiyanti, R., and Sabir, M. (2013).
Sccmec type II gene is common among clinical isolates of methicillin-resistant
Staphylococcus aureus in Jakarta, Indonesia. BMC Res. Notes 6:110. doi:
10.1186/1756-0500-6-110
Byrgazov, K., Vesper, O., and Moll, I. (2013). Ribosome heterogeneity: another
level of complexity in bacterial translation regulation. Curr. Opin. Microbiol.
16, 133–139. doi: 10.1016/j.mib.2013.01.009
Chambers, H. F. (1997). Methicillin resistance in staphylococci: molecular and
biochemical basis and clinical implications. Clin. Microbiol. Rev. 10, 781–791.
Chen, H., Liu, Y., Zhao, C., Xiao, D., Zhang, J., Zhang, F., et al. (2013).
Comparative proteomics-based identiﬁcation of genes associated with
glycopeptide resistance in clinically derived heterogeneous vancomycin-
intermediate Staphylococcus aureus strains. PLoS ONE 8:e66880. doi:
10.1371/journal.pone.0066880
Cordwell, S. J., Larsen, M. R., Cole, R. T., and Walsh, B. J. (2002). Comparative
proteomics of Staphylococcus aureus and the response of methicillin-resistant
andmethicillin-sensitive strains to Triton X-100.Microbiology. 148, 2765–2781.
doi: 10.1099/00221287-148-9-2765
Cosgrove, K., Coutts, G., Jonsson, I. M., Tarkowski, A., Kokai-Kun, J. F., Mond, J.
J., et al. (2007). Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have
compensatory roles in peroxide stress resistance and are required for survival,
persistence, and nasal colonization in Staphylococcus aureus. J. Bacteriol. 189,
1025–1035. doi: 10.1128/JB.01524-06
Courvalin, P. (2005). Genetics of glycopeptide resistance in gram-
positive pathogens. Int. J. Med. Microbiol. 294, 479–486. doi:
10.1016/j.ijmm.2004.10.002
Cuaron, J. A., Dulal, S., Song, Y., Singh, A. K., Montelongo, C. E., Yu, W.,
et al. (2013). Tea tree oil-induced transcriptional alterations in Staphylococcus
aureus. Phytother. Res. 27, 390–396. doi: 10.1002/ptr.4738
Cui, L., Lian, J. Q., Neoh, H. M., Reyes, E., and Hiramatsu, K. (2005).
DNA microarray-based identiﬁcation of genes associated with glycopeptide
resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 49,
3404–3413. doi: 10.1128/AAC.49.8.3404-3413.2005
Delaune, A., Poupel, O., Mallet, A., Coic, Y. M., Msadek, T., and Dubrac,
S. (2011). Peptidoglycan crosslinking relaxation plays an important role in
Staphylococcus aureus WalKR-dependent cell viability. PLoS ONE 6:e17054.
doi: 10.1371/journal.pone.0017054
Dengler, V., Meier, P. S., Heusser, R., Berger-Bächi, B., and McCallum, N. (2011).
Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in
response to diﬀerent cell wall active antibiotics. BMC Microbiol. 11:16. doi:
10.1186/1471-2180-11-16
Drummelsmith, J., Winstall, E., Bergeron, M. G., Poirier, G. G., and Ouellette,
M. (2007). Comparative proteomics analyses reveal a potential biomarker
for the detection of vancomycin-intermediate Staphylococcus aureus strains.
J. Proteome Res. 6, 4690–4702. doi: 10.1021/pr070521m
Enany, S., Yoshida, Y., and Yamamoto, T. (2014). Exploring extra-cellular proteins
in methicillin susceptible and methicillin resistant Staphylococcus aureus
by liquid chromatography-tandem mass spectrometry. World J. Microbiol.
Biotechnol. 30, 1269–1283. doi: 10.1007/s11274-013-1550-7
Fan, X., Liu, Y., Smith, D., Konermann, L., Siu, K. W., and Golemi-
Kotra, D. (2007). Diversity of penicillin-binding proteins. Resistance factor
FmtA of Staphylococcus aureus. J. Biol. Chem. 282, 35143–35152. doi:
10.1074/jbc.M706296200
Feng, J., Billal, D. S., Lupien, A., Racine, G., Winstall, E., Légaré, D., et al. (2011).
Proteomic and transcriptomic analysis of linezolid resistance in Streptococcus
pneumoniae. J. Proteome Res. 10, 4439–4452. doi: 10.1021/pr200221s
Fischer, A., Yang, S. J., Bayer, A. S., Vaezzadeh, A. R., Herzig, S., Stenz, L., et al.
(2011). Daptomycin resistance mechanisms in clinically derived Staphylococcus
aureus strains assessed by a combined transcriptomics and proteomics
approach. J. Antimicrob. Chemother. 66, 1696–1711. doi: 10.1093/jac/dkr195
Friedberg, E. C., Wagner, R., and Radman, M. (2002). Specialized DNA
polymerases, cellular survival, and the genesis of mutations. Science 296,
1627–1630. doi: 10.1126/science.1070236
Gardete, S., Wu, S. W., Gill, S., and Tomasz, A. (2006). Role of VraSR in antibiotic
resistance and antibiotic-induced stress response in Staphylococcus aureus.
Antimicrob. Agents Chemother. 50, 3424–3434. doi: 10.1128/AAC.00356-06
Gov, Y., Borovok, I., Korem, M., Singh, V. K., Jayaswal, R. K., Wilkinson, B. J.,
et al. (2004). Quorum sensing in Staphylococci is regulated via phosphorylation
of three conserved histidine residues. J. Biol. Chem. 279, 14665–14672. doi:
10.1074/jbc.M311106200
Hachmann, A. B., Angert, E. R., and Helmann, J. D. (2009). Genetic analysis of
factors aﬀecting susceptibility of Bacillus subtilis to daptomycin. Antimicrob.
Agents Chemother. 53, 1598–1609. doi: 10.1128/AAC.01329-08
Hanaki, H., Inaba, Y., Sasaki, K., and Hiramatsu, K. (1998). A novel method
of detecting Staphylococcus aureus heterogeneously resistant to vancomycin
(hetero-VRSA). Jpn. J. Antibiot. 51, 521–530.
Hao, H., Dai, M., Wang, Y., Huang, L., and Yuan, Z. (2012). Key genetic elements
and regulation systems in methicillin-resistant Staphylococcus aureus. Future
Microbiol. 7, 1315–1329. doi: 10.2217/fmb.12.107
Healy, V. L., Lessard, I. A., Roper, D. I., Knox, J. R., and Walsh, C. T. (2000).
Vancomycin resistance in enterococci: reprogramming of the D-Ala-D-Ala
ligases in bacterial peptidoglycan biosynthesis. Chem. Biol. 7, R109–R119. doi:
10.1016/s1074-5521(00)00116-2
Herrmann, D. J., Peppard, W. J., Ledeboer, N. A., Theesfeld, M. L., Weigelt,
J. A., and Buechel, B. J. (2008). Linezolid for the treatment of drug-
resistant infections. Expert Rev. Anti. Infect. Ther. 6, 825–848. doi:
10.1586/14787210.6.6.825
Hessling, B., Bonn, F., Otto, A., Herbst, F. A., Rappen, G. M., Bernhardt, J.,
et al. (2013). Global proteome analysis of vancomycin stress in Staphylococcus
aureus. Int. J. Med. Microbiol. 303, 624–634. doi: 10.1016/j.ijmm.2013.08.014
Hobbs, J. K., Miller, K., O’Neill, A. J., and Chopra, I. (2008). Consequences
of daptomycin-mediated membrane damage in Staphylococcus aureus.
J. Antimicrob. Chemother. 62, 1003–1008. doi: 10.1093/jac/dkn321
Howden, B. P., and Grayson, M. L. (2006). Dumb and dumber-the potential
waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in
Staphylococcus aureus. Clin. Infect. Dis. 42, 394–400. doi: 10.1086/499365
Ippolito, J. A., Kanyo, Z. F., Wang, D., Franceschi, F. J., Moore, P. B., Steitz,
T. A., et al. (2008). Crystal structure of the oxazolidinone antibiotic linezolid
bound to the 50S ribosomal subunit. J. Med. Chem. 51, 3353–3356. doi:
10.1021/jm800379d
Joly, N., Engl, C., Jovanovic, G., Huvet, M., Toni, T., Sheng, X., et al. (2010).
Managing membrane stress: the phage shock protein (Psp) response, from
molecular mechanisms to physiology. FEMS Microbiol. Rev. 34, 797–827. doi:
10.1111/j.1574-6976.2010.00240.x
Jones, T., Yeaman, M. R., Sakoulas, G., Yang, S. J., Proctor, R. A., Sahl, H. G.,
et al. (2008). Failures in clinical treatment of Staphylococcus aureus Infection
with daptomycin are associated with alterations in surface charge, membrane
phospholipid asymmetry, and drug binding.Antimicrob. Agents Chemother. 52,
269–278. doi: 10.1128/AAC.00719-07
Jordan, S., Junker, A., Helmann, J. D., and Mascher, T. (2006). Regulation
of LiaRS-dependent gene expression in bacillus subtilis: identiﬁcation of
inhibitor proteins, regulator binding sites, and target genes of a conserved cell
envelope stress-sensing two-component system. J. Bacteriol. 188, 5153–5166.
doi: 10.1128/JB.00310-06
Jousselin, A., Renzoni, A., Andrey, D. O., Monod, A., Lew, D. P., and Kelley, W. L.
(2012). The posttranslocational chaperone lipoprotein PrsA is involved in both
glycopeptide and oxacillin resistance in Staphylococcus aureus. Antimicrob.
Agents Chemother. 56, 3629–3640. doi: 10.1128/AAC.06264-11
Katayama, Y., Zhang, H. Z., and Chambers, H. F. (2004). PBP 2a mutations
producing very-high-level resistance to β-lactams. Antimicrob. Agents
Chemother. 48, 453–459. doi: 10.1128/AAC.48.2.453-459.2004
Koripella, R. K., Chen, Y., Peisker, K., Koh, C. S., Selmer, M., and Sanyal, S. (2012).
Mechanism of elongation factor-G-mediated fusidic acid resistance and ﬁtness
Frontiers in Microbiology | www.frontiersin.org 27 August 2015 | Volume 6 | Article 828
Lee et al. Proteomic approach of antibiotic resistance
compensation in Staphylococcus aureus. J. Biol. Chem. 287, 30257–30267. doi:
10.1074/jbc.M112.378521
Kuroda, M., Kuroda, H., Oshima, T., Takeuchi, F., Mori, H., and Hiramatsu, K.
(2003). Two-component system VraSR positively modulates the regulation of
cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49,
807–821. doi: 10.1046/j.1365-2958.2003.03599.x
Kuroda, M., Kuwahara-Arai, K., and Hiramatsu, K. (2000). Identiﬁcation of the
up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus
strains Mu3 and Mu50 by cDNA diﬀerential hybridization method. Biochem.
Biophys. Res. Commun. 269, 485–490. doi: 10.1006/bbrc.2000.2277
Lee, C. R., Cho, I. H., Jeong, B. C., and Lee, S. H. (2013). Strategies to minimize
antibiotic resistance. Int. J. Environ. Res. Public Health. 10, 4274–4305. doi:
10.3390/ijerph10094274
Lee, J. H., Bae, I. K., and Lee, S. H. (2012). New deﬁnitions of extended-spectrum β-
lactamase conferring worldwide emerging antibiotic resistance. Med. Res. Rev.
32, 216–232. doi: 10.1002/med.20210
Levine, D. P. (2006). Vancomycin: a history. Clin. Infect. Dis. 42(Suppl. 1), S5–S12.
doi: 10.1086/491709
Long, K. S., and Vester, B. (2012). Resistance to linezolid caused by modiﬁcations
at its binding site on the ribosome.Antimicrob. Agents Chemother. 56, 603–612.
doi: 10.1128/AAC.05702-11
Lorenz, U., Lorenz, B., Schmitter, T., Streker, K., Erck, C., Wehland, J.,
et al. (2011). Functional antibodies targeting IsaA of Staphylococcus aureus
augment host immune response and open new perspectives for antibacterial
therapy. Antimicrob. Agents Chemother. 55, 165–173. doi: 10.1128/AAC.
01144-10
Marcone, G. L., Beltrametti, F., Binda, E., Carrano, L., Foulston, L., Hesketh,
A., et al. (2010). Novel mechanism of glycopeptide resistance in the A40926
producer Nonomuraea sp. ATCC 39727. Antimicrob. Agents Chemother. 54,
2465–2472. doi: 10.1128/AAC.00106-10
Matsuno, K., and Sonenshein, A. L. (1999). Role of SpoVG in asymmetric septation
in Bacillus subtilis. J. Bacteriol. 181, 3392–3401.
McAleese, F., Wu, S. W., Sieradzki, K., Dunman, P., Murphy, E., Projan,
S., et al. (2006). Overexpression of genes of the cell wall stimulon in
clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-
S. aureus-type resistance to vancomycin. J. Bacteriol. 188, 1120–1133. doi:
10.1128/JB.188.3.1120-1133.2006
Mehta, S., Cuirolo, A. X., Plata, K. B., Riosa, S., Silverman, J. A., Rubio, A.,
et al. (2012). VraSR two-component regulatory system contributes to mprF-
mediated decreased susceptibility to daptomycin in in vivo-selected clinical
strains of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents
Chemother. 56, 92–102. doi: 10.1128/AAC.00432-10
Mendes, R. E., Deshpande, L. M., and Jones, R. N. (2014). Linezolid update:
stable in vitro activity following more than a decade of clinical use and
summary of associated resistance mechanisms. Drug Resist. Updat. 17, 1–12.
doi: 10.1016/j.drup.2014.04.002
Miao, V., Coëﬀet-Legal, M. F., Brian, P., Brost, R., Penn, J., Whiting, A.,
et al. (2005). Daptomycin biosynthesis in Streptomyces roseosporus: cloning
and analysis of the gene cluster and revision of peptide stereochemistry.
Microbiology 151, 1507–1523. doi: 10.1099/mic.0.27757-0
Mishra, N. N., Yang, S. J., Sawa, A., Rubio, A., Nast, C. C., Yeaman, M.
R., et al. (2009). Analysis of cell membrane characteristics of in vitro-
selected daptomycin-resistant strains of methicillin-resistant Staphylococcus
aureus. Antimicrob. Agents Chemother. 53, 2312–2318. doi: 10.1128/AAC.
01682-08
Moher, D., Liberati, A., Tetzlaﬀ, J., Altman, D. G., and Group, P. (2009). Preferred
reporting items for systematic reviews and meta-analyses: the PRISMA
statement. PLoS Med. 6:e1000097. doi: 10.1371/journal.pmed.1000097
Mongodin, E., Finan, J., Climo, M. W., Rosato, A., Gill, S., and Archer,
G. L. (2003). Microarray transcription analysis of clinical Staphylococcus
aureus isolates resistant to vancomycin. J. Bacteriol. 185, 4638–4643. doi:
10.1128/JB.185.15.4638-4643.2003
Muthaiyan, A., Silverman, J. A., Jayaswal, R. K., and Wilkinson, B. J.
(2008). Transcriptional proﬁling reveals that daptomycin induces the
Staphylococcus aureus cell wall stress stimulon and genes responsive to
membrane depolarization. Antimicrob. Agents Chemother. 52, 980–990. doi:
10.1128/AAC.01121-07
Napolitano, R., Janel-Bintz, R., Wagner, J., and Fuchs, R. P. (2000). All three SOS-
inducible DNA polymerases (Pol II, Pol IV and Pol V) are involved in induced
mutagenesis. EMBO J. 19, 6259–6265. doi: 10.1093/emboj/19.22.6259
Newsom, S. W. (2004). MRSA—past, present, future. J. R. Soc. Med. 97, 509–510.
doi: 10.1258/jrsm.97.11.509
Perry, S. E., and Edwards, D. H. (2004). Identiﬁcation of a polar targeting
determinant for Bacillus subtilis DivIVA. Mol. Microbiol. 54, 1237–1249. doi:
10.1111/j.1365-2958.2004.04363.x
Pieper, R., Gatlin-Bunai, C. L., Mongodin, E. F., Parmar, P. P., Huang, S. T.,
Clark, D. J., et al. (2006). Comparative proteomic analysis of Staphylococcus
aureus strains with diﬀerences in resistance to the cell wall-targeting antibiotic
vancomycin. Proteomics. 6, 4246–4258. doi: 10.1002/pmic.200500764
Pietiäinen, M., François, P., Hyyryläinen, H. L., Tangomo, M., Sass, V., Sahl, H. G.,
et al. (2009). Transcriptome analysis of the responses of Staphylococcus aureus
to antimicrobial peptides and characterization of the roles of vraDE and vraSR
in antimicrobial resistance. BMC Genomics. 10:429. doi: 10.1186/1471-2164-
10-429
Pogliano, J., Pogliano, N., and Silverman, J. A. (2012). Daptomycin-mediated
reorganization of membrane architecture causes mislocalization of essential cell
division proteins. J. Bacteriol. 194, 4494–4504. doi: 10.1128/JB.00011-12
Radhouani, H., Pinto, L., Poeta, P., and Igrejas, G. (2012). After genomics, what
proteomics tools could help us understand the antimicrobial resistance of
Escherichia coli? J. Proteomics. 75, 2773–2789. doi: 10.1016/j.jprot.2011.12.035
Ramos, S., Chafsey, I., Silva, N., Hébraud, M., Santos, H., Capelo-Martinez,
J. L., et al. (2015). Eﬀect of vancomycin on the proteome of the
multiresistant Enterococcus faecium SU18 strain. J. Proteomics. 113, 378–387.
doi: 10.1016/j.jprot.2014.10.012
Reyes, J., Panesso, D., Tran, T. T., Mishra, N. N., Cruz, M. R., Munita, J.
M., et al. (2015). A liaR deletion restores susceptibility to daptomycin and
antimicrobial peptides in multidrug-resistant Enterococcus faecalis. J. Infect.
Dis. 211, 1317–1325. doi: 10.1093/infdis/jiu602
Rogers, P. D., Liu, T. T., Barker, K. S., Hilliard, G. M., English, B. K.,
Thornton, J., et al. (2007). Gene expression proﬁling of the response of
Streptococcus pneumoniae to penicillin. J. Antimicrob. Chemother. 59, 616–626.
doi: 10.1093/jac/dkl560
Sasindran, S. J., Saikolappan, S., and Dhandayuthapani, S. (2007). Methionine
sulfoxide reductases and virulence of bacterial pathogens. Future Microbiol. 2,
619–630. doi: 10.2217/17460913.2.6.619
Sass, P., Jansen, A., Szekat, C., Sass, V., Sahl, H. G., and Bierbaum, G. (2008).
The lantibiotic mersacidin is a strong inducer of the cell wall stress response
of Staphylococcus aureus. BMCMicrobiol. 8:186. doi: 10.1186/1471-2180-8-186
Scherl, A., François, P., Charbonnier, Y., Deshusses, J. M., Koessler, T., Huyghe,
A., et al. (2006). Exploring glycopeptide-resistance in Staphylococcus aureus:
a combined proteomics and transcriptomics approach for the identiﬁcation
of resistance-related markers. BMC Genomics. 7:296. doi: 10.1186/1471-
2164-7-296
Schulthess, B., Bloes, D. A., and Berger-Bachi, B. (2012). Opposing roles of σB and
σB-controlled SpoVG in the global regulation of esxA in Staphylococcus aureus.
BMCMicrobiol. 12:17. doi: 10.1186/1471-2180-12-17
Schulthess, B., Meier, S., Homerova, D., Goerke, C., Wolz, C., Kormanec, J., et al.
(2009). Functional characterization of the σB-dependent yabJ-spoVG operon
in Staphylococcus aureus: role in methicillin and glycopeptide resistance.
Antimicrob. Agents Chemother. 53, 1832–1839. doi: 10.1128/AAC.01255-08
Schumacher, A., Trittler, R., Bohnert, J. A., Kümmerer, K., Pages, J. M., and
Kern, W. V. (2007). Intracellular accumulation of linezolid in Escherichia
coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced eﬄux
pump activity and inactivation. J. Antimicrob. Chemother. 59, 1261–1264. doi:
10.1093/jac/dkl380
Seidl, K., Stucki, M., Ruegg, M., Goerke, C., Wolz, C., Harris, L., et al. (2006).
Staphylococcus aureus CcpA aﬀects virulence determinant production and
antibiotic resistance. Antimicrob. Agents Chemother. 50, 1183–1194. doi:
10.1128/AAC.50.4.1183-1194.2006
Sobral, R. G., Jones, A. E., Des Etages, S. G., Dougherty, T. J., Peitzsch, R.
M., Gaasterland, T., et al. (2007). Extensive and genome-wide changes in
the transcription proﬁle of Staphylococcus aureus induced by modulating the
transcription of the cell wall synthesis gene murF. J. Bacteriol. 189, 2376–2391.
doi: 10.1128/JB.01439-06
Frontiers in Microbiology | www.frontiersin.org 28 August 2015 | Volume 6 | Article 828
Lee et al. Proteomic approach of antibiotic resistance
Song, Y., Rubio, A., Jayaswal, R. K., Silverman, J. A., and Wilkinson, B. J. (2013).
Additional routes to Staphylococcus aureus daptomycin resistance as revealed
by comparative genome sequencing, transcriptional proﬁling, and phenotypic
studies. PLoS ONE 8:e58469. doi: 10.1371/journal.pone.0058469
Stapleton, M. R., Horsburgh, M. J., Hayhurst, E. J., Wright, L., Jonsson, I. M.,
Tarkowski, A., et al. (2007). Characterization of IsaA and SceD, two putative
lytic transglycosylases of Staphylococcus aureus. J. Bacteriol. 189, 7316–7325.
doi: 10.1128/JB.00734-07
Stülke, J., and Hillen, W. (2000). Regulation of carbon catabolism in
Bacillus species. Annu. Rev. Microbiol. 54, 849–880. doi: 10.1146/annurev.
micro.54.1.849
Swaney, S. M., Aoki, H., Ganoza, M. C., and Shinabarger, D. L. (1998). The
oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria.
Antimicrob. Agents Chemother. 42, 3251–3255.
Tettelin, H., Nelson, K. E., Paulsen, I. T., Eisen, J. A., Read, T. D., Peterson, S.,
et al. (2001). Complete genome sequence of a virulent isolate of Streptococcus
pneumoniae. Science 293, 498–506. doi: 10.1126/science.1061217
Utaida, S., Dunman, P. M., Macapagal, D., Murphy, E., Projan, S. J., Singh, V.
K., et al. (2003). Genome-wide transcriptional proﬁling of the response of
Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress
stimulon.Microbiology 149, 2719–2732. doi: 10.1099/mic.0.26426-0
van der Voort, M., Kuipers, O. P., Buist, G., de Vos, W. M., and Abee, T.
(2008). Assessment of CcpA-mediated catabolite control of gene expression
in Bacillus cereus ATCC 14579. BMC Microbiol. 8:62. doi: 10.1186/1471-
2180-8-62
Wang, X., He, X., Jiang, Z., Wang, J., Chen, X., Liu, D., et al. (2010). Proteomic
analysis of the Enterococcus faecalis V583 strain and clinical isolate V309
under vancomycin treatment. J. Proteome Res. 9, 1772–1785. doi: 10.1021/pr90
1216e
Wecke, T., Zuhlke, D., Mäder, U., Jordan, S., Voigt, B., Pelzer, S., et al. (2009).
Daptomycin versus Friulimicin B: in-depth proﬁling of Bacillus subtilis cell
envelope stress responses. Antimicrob. Agents Chemother. 53, 1619–1623. doi:
10.1128/AAC.01046-08
Wilson, D. N., Schluenzen, F., Harms, J. M., Starosta, A. L., Connell,
S. R., and Fucini, P. (2008). The oxazolidinone antibiotics perturb
the ribosomal peptidyl-transferase center and eﬀect tRNA positioning.
Proc. Natl. Acad. Sci. U.S.A. 105, 13339–13344. doi: 10.1073/pnas.08042
76105
Winkler, M. E., and Hoch, J. A. (2008). Essentiality, bypass, and targeting of the
YycFG (VicRK) two-component regulatory system in gram-positive bacteria.
J. Bacteriol. 190, 2645–2648. doi: 10.1128/JB.01682-07
Woodford, N. (1998). Glycopeptide-resistant enterococci: a decade of experience.
J. Med. Microbiol. 47, 849–862.
Yin, S., Daum, R. S., and Boyle-Vavra, S. (2006). VraSR two-component regulatory
system and its role in induction of pbp2 and vraSR expression by cell wall
antimicrobials in Staphylococcus aureus. Antimicrob. Agents Chemother. 50,
336–343. doi: 10.1128/AAC.50.1.336-343.2006
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or ﬁnancial relationships that could
be construed as a potential conﬂict of interest.
Copyright © 2015 Lee, Lee, Park, Jeong and Lee. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 29 August 2015 | Volume 6 | Article 828
